Tag: CBT > Cannabis Health Research: Page 7

Legislation and Regulation

Senate Committee Hearing Emphasizes the Need for Policy Change to Increase Cannabis Research Access

This week, Senators Feinstein and Cornyn convened a panel of leading health experts to uncover the health impact of cannabis on consumers. Instead, they were hit with the realization that the only way to determine those impacts is through increased research access.

October 25, 2019

Hemp Research

CBD for Arthritic Dogs: University 'Clinical' Trial

University of Pennsylvania set to partner with Denver-based Dixie Brands, Inc. in first-ever double-blind placebo CBD trial for dogs suffering from osteoarthritis.

October 11, 2019

International

Cannabis Goes Down Under for First-Ever Human Trial on Dementia

The Institute for Health Research at University of Notre Dame in Western Australia recently announced the start of a ground-breaking clinical trial to discover how cannabis can alleviate symptoms associated with dementia.

October 7, 2019

Interviews & Opinion

How Leafly’s New Cannabis Guide Will Impact Businesses’ Relationships With Consumers and Patients

Leafly has designed a new system to help consumers visualize the “ingredients” that make up unique chemical profiles in cannabis.

October 4, 2019

Interviews & Opinion

Responding to the Recent U.S. Surgeon General Cannabis Advisory

The language—and the evidence—we use to describe cannabis is important to the industry's success.

October 2, 2019